Randomised controlled trial of telephone based cognitive behavioural therapy (CBT) for patients with chronic lung disease and anxiety and/or depression undergoing pulmonary rehabilitation to evaluate the effect on symptoms of anxiety and depression, quality of life, and exacerbations

Randomised controlled trial of a brief telephone based cognitive behavioural therapy (CBT) for patients with chronic lung disease and anxiety and/or depression undergoing pulmonary rehabilitation to evaluate the effect on quality of life, symptoms of anxiety and depression, and exacerbation rate

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12614000915651

Enrollment

Registered

2014-08-27

Start date

2015-04-15

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this study is to assess the impact and viability of CBT as a treatment for patients with chronic lung disease undergoing pulmonary rehabilitation. We expect that CBT and rehabilitation will have a synergic effect, enhancing rehabilitation benefits and improving patients’ quality of life through improved patients coping skills and psychological and physical well being

Interventions

Intervention will be 6 Cognitive behavioural therapy (CBT) sessions administered by psychology interns Usual care compromised of medical treatment and pulmonary rehabilitation 6 Cognitive behavioural therapy (CBT) sessions will be divided into: 2 face-to-face individual sessions of 1 hour each, within the first 4 weeks of pulmonary rehabilitation 4 phone sessions of 60 minutes each will be undertaken for counseling, each session will be fortnightly within the first 2 months after the face-to-fac

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

Chronic Lung disease Undergoing pulmonary rehabilitation Clinical or subclinical anxiety or depression, defined by Geriatric Anxiety Inventory (GAI) score greater or equal to 4/20 , and/or Geriatric Depression scale (GDS) of greater or equal to 4/15

Exclusion criteria

Inability to give written informed consent. Known psychotic disorder. Cognitive impairment determined by Montreal Cognitive Assessment (MOCA) score of <25/30. Current enrolment in other interventional clinical trials that would potentially interfere with this study.

Outcome results